Elegen
Latest round
- Series B
Last raised
- May 2024
Total raised
- $35M
Investors
- 10
About Elegen
Established in 2017 by Matthew Hilland based in California, US, Elegen Corp.In May 2024, Elegen Corp. Andreessen Horowitz, KdT Ventures, 8VC, Digitalis Ventures, ACVC Partners, Alix Ventures, AME Cloud Ventures, and Agilent Technologies. Elegen Corporation's core product offering is ENFINIA DNA, a high-accuracy, cell-free DNA synthesis technology designed to produce long, complex, linear DNA sequences that enable clients to access synthetic DNA, reducing the traditional timeframes required for DNA synthesis and assembly. Customers include genetic medicine developers, researchers in synthetic biology, and organizations engaged in gene therapy, particularly those focused on mRNA vaccine development and advanced genetic research. ENFINIA DNA is utilized globally, with demand in North America, Europe, and Asia. This technology allows users to streamline their workflows by minimizing or eliminating the need for cloning practices, thus expediting critical research timelines. The company generates revenue through direct sales of its ENFINIA DNA synthesis services, which are primarily targeted at B2B clients within the biotechnology and pharmaceutical sectors.
Who invested in Elegen
10 investors across 1 round
See all investors in Elegen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
May 14, 2024
Amount
$35M
Investors
Questions about Elegen
Who invested in Elegen?
Elegen has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Elegen raised?
Elegen has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Elegen last raise money?
Elegen's most recent round on record is a Series B, in May 2024.
What does Elegen do?
Established in 2017 by Matthew Hilland based in California, US, Elegen Corp.
Where is Elegen headquartered?
Elegen is headquartered in San Carlos, US.
Which VCs invest in companies like Elegen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Elegen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Elegen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.